Skip to search.
 FTSE 100 Down 0.93%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
0.56 Down 0.01(2.22%) 17 Apr 21:00
|After Hours: : 0.57 Up 0.01 (0.96%) 17 Apr 21:15
Add to Portfolio
Prev Close:0.58
Open:0.58
Bid:0.55 x 1200
Ask:0.70 x 2000
1y Target Est:5.00
Beta:4.3
Earnings Date:6 May - 11 May (Est.)
Day's Range:0.54 - 0.58
52wk Range:0.36 - 2.66
Volume:635,633
Avg Vol (3m):1,258,120
Market Cap:18.59m
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KBIO at this time.

Comparison

Symbol% ChgMkt Cap
KBIODown 2.22%18.59m
VRTXDown 3.00%30.28b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.34
Quarterly EPS Est (Mar-15) :-0.30
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback